The "Biopharmaceutical Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034" report has been added to ResearchAndMarkets.com's offering.The Global Biopharmaceutical ...

The latecomer PD-1 inhibitor – already approved for Merkel cell carcinoma – has become the first cancer immunotherapy for ...

As per the latest analysis, the biosimilar and biologics market value is estimated to reach USD 520.9 billion in 2024. Global sales of biosimilars and biologics will likely increase at 7.6% CAGR ...

Seoul: Celltrion, a leading South Korean biopharmaceutical company, on Thursday said its business will remain largely ...

Billionaire hedge‑fund manager Bill Ackman is declaring an ideological victory after President Trump’s latest Truth Social ...

Celltrion Group Chair and founder Seo Jung-jin downplayed concerns over potential fallout from recent US policy and tariff ...

LONDON, GREATER LONDON, UNITED KINGDOM, May 15, 2025 /EINPresswire.com/ -- What Does The Market Size Indicate About The Market Dynamics? The pemphigus vulgaris market size has grown strongly in recent ...

SEOUL, May 15 (Yonhap) -- Celltrion Inc., a leading South Korean biopharmaceutical company, said Thursday its business will ...

European Commission President Ursula von der Leyen has lost a lawsuit attempting to force her to disclose text messages with ...

Market is undergoing a transformative phase, driven by the increasing demand for precision medicine and targeted therapies.

Of course, there are countless value stocks that are worth mentioning, but this is a concise list of the top 6 undervalued stocks in the Pharmaceuticals industry for Tuesday, May 13, 2025. Let’s take ...